Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021

Abstract

Adrenocortical carcinoma (ACC) is an extremely rare malignancy, whose molecular pathogenesis is incompletely understood [1] and treatment strategies are limited [2]. An international Symposium, held in Ann Arbor in 2003 [3], stimulated international collaborations. Since then, the ACC international research community has grown over time and meets every 2 years in a Symposium where advances in the pathogenesis and therapy of this rare disease are discussed. The 8th edition of this Symposium was organized by Alfredo Berruti and Massimo Terzolo and was held in Brescia from September 30 to October 2, in a Webinar mode due to SARS COV-2 pandemic. The webinar organization favored the widespread of Conference, which attracted more than 600 scientists from different countries. The 2021 meeting covered a broad range of topics related to advances in preclinical and clinical researches. It was organized in a number of sessions, aligned to a specific theme, research area or clinical issue. Sessions included lectures and oral communications on leading research related to molecular heterogeneity of adrenocortical tumors, new insights from preclinical studies, progress in surgical treatment, adjuvant therapies, management of advanced disease and future perspectives and proposals of new clinical studies. As previous editions, this productive Symposium served to educate, enhance discovery, and facilitate the development of effective strategies for this rare disease.